EFFECTS OF NIFEDIPINE AND MOXONIDINE ON CARDIAC STRUCTURE IN SPONTANEOUSLY HYPERTENSIVE RATS - STEREOLOGICAL STUDIES ON MYOCYTES, CAPILLARIES, ARTERIES, AND CARDIAC INTERSTITIUM

被引:25
作者
AMANN, K [1 ]
GREBER, D [1 ]
GHAREHBAGHI, H [1 ]
WIEST, G [1 ]
LANGE, B [1 ]
GANTEN, U [1 ]
MATTFELDT, T [1 ]
MALL, G [1 ]
机构
[1] UNIV HEIDELBERG,DEPT PATHOL,W-6900 HEIDELBERG,GERMANY
关键词
MYOCARDIUM; STEREOLOGY; HYPERTENSION;
D O I
10.1093/ajh/5.2.76
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Light and electron microscopic stereological studies were performed on the myocardium of spontaneously hypertensive rats (SHR-SP) before and after treatment with nifedipine (27 mg/kg body weight/day) and the antisympathotonic agent moxonidine (8 mg/kg body weight/day). The treated groups were compared with nontreated SHR-SP and normotensive WKY (n = 10 in each group). At the beginning of therapy (when the male SHR-SP were 6 months old), blood pressure was increased and left ventricular hypertrophy had developed whereas pathologic changes of myocardial structure were not observed. After 3 months, the nontreated hypertensive rats showed cardiac fibrosis, activation and proliferation of interstitial cells, wall thickening of intramyocardial arteries, reduced capillarization as well as focal degeneration of myocytes at the ultrastructural level. Both treatments showed similar effects on blood pressure, degree of hypertrophy, and cardiac structure. Blood pressure as well as the degree of hypertrophy were significantly reduced. As far as myocardial fibrosis, capillarization, and regressive changes of myocytes are concerned a complete normalization was observed. Furthermore, nifedipine enhanced capillary supply beyond the normal level by induction of capillary neoformation. Microarteriopathy and activation of nonvascular interstitial cells (first step in development of interstitial myocardial fibrosis) were significantly suppressed by therapy, but the level of the normotensive control could not be maintained. Additional experiments with a low dose combination therapy of nifedipine and moxonidine that did not reduce blood pressure provided evidence that hypertension is an important determinant of the alterations of intramyocardial arteries, but not of cardiac interstitial fibrosis.
引用
收藏
页码:76 / 83
页数:8
相关论文
共 35 条
[1]  
McKee P.A., Castelli W.P., McNamara P.M., Kannel W.B., The natural history of congestive heart failure: The Framingham study, N Eng J Med, 285, pp. 1441-1446, (1971)
[2]  
Jacob R., Different fractions in the normal and hypertrophied rat ventricular myocardium: An analysis of two models of hypertrophy, Basic Res Cardiol, 71, pp. 608-623, (1976)
[3]  
Klepzig M., Eisenlohr H., Steindl S., Et al., Media hypertrophy in hypertensive coronary resistance vessels, J. Cardiovasc Pharmacol, 10, pp. 97-102, (1987)
[4]  
Mall G., Mattfeldt T., Hasslacher C., Mann J., Morphologic reaction patterns in experimental cardiac hypertrophy, Basic Res Cardiol, 81, pp. 193-201, (1986)
[5]  
Mall G., Klingel K., Hasslacher C., Et al., Synergistic effects of diabetes mellitus and renovascular hypertension on the rat heart—stereological investigations on papillary muscles, Virchows Archiv [A], 411, pp. 531-542, (1987)
[6]  
Tanaka M., Fujiwara H., Onodera T., Et al., Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy, Br Heart J, 55, pp. 575-581, (1986)
[7]  
Thiedemann K.-U., Holubarsch C., Medugorac I., Jacob R., Connective tissue content and myocardial stiffness in pressure overload hypertrophy—a combined study of morphologic, morphometric, biochemical, and mechanical parameters, Basic Res Cardiol, 78, pp. 140-155, (1983)
[8]  
Weber K.T., Cardiac interstitium in health and disease: The fibrillar collagen network, J am Coll Cardiol, 13, pp. 1637-1652, (1989)
[9]  
Eichstaedt H., Richter W., Baeder M., Et al., Demonstration of hypertrophy-regression with magnetic resonance tomography under the new adrenergic inhibitor monoxi- dine (Abst), Cardiovasc Drugs, 3, (1989)
[10]  
Ram C., Regression of left ventricular hypertrophy in hypertension with alpha-adrenergic blockade: Physiological basis and therapeutic implications, J Hypertens, 7, pp. 98-99, (1989)